SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-100970
Filing Date
2011-04-18
Accepted
2011-04-18 16:27:50
Documents
3
Period of Report
2011-04-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 19395
2 PRESS RELEASE dex991.htm EX-99.1 8941
3 GRAPHIC g175802g73i52.jpg GRAPHIC 2838
  Complete submission text file 0001193125-11-100970.txt   33696
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 11765756
SIC: 2834 Pharmaceutical Preparations